Current Edition


Pfizer’s COVID pill Paxlovid gets boost in Britain thanks to spot in national trial

Pfizer’s COVID-19 vaccine and antiviral show little sign of slowing down in the pandemic’s third year. Now, the company’s oral therapy is getting a boost …

Continue Reading →

Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit

It wasn’t supposed to be this way. Zealand Pharma should be in the honeymoon glow of its first drug launch with a drug approved less …

Continue Reading →

Biogen’s Aduhelm call to action backfires as CMS receives many more comments in favor of restrictive coverage: analyst

During a January Q&A call with investors, Biogen chief Michel Vounatsos pressed Aduhelm supporters to fight the Centers for Medicare & Medicaid Services’ (CMS’) restrictive …

Continue Reading →

Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s Dupixent in eczema

Look out, Sanofi and Regeneron: Pfizer is on the scene in atopic dermatitis with another blockbuster-to-be. Friday, the FDA approved the New York drugmaker’s oral …

Continue Reading →

Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo

The FDA blessed Idorsia’s Quviviq (daridorexant), a sleeping pill for those with insomnia. Because the FDA has recommended Idorsia to register Quviviq as a controlled substance, the …

Continue Reading →

Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe

Despite classwide safety worries in the U.S., AbbVie is making strides in its quest to build immunology up-and-comer Rinvoq. AbbVie sent off applications to U.S. and …

Continue Reading →

Finding the Right Patients for Primary Care Clinical Studies

Automated Recruitment Platforms (ARPs) offer primary care clinicians and allied health professionals’ opportunities for more time-efficient ways to engage with and recruit patients for clinical …

Continue Reading →

Feedback from Parkinson’s Patients Can Help Improve Trial Recruitment, Retention, Study Says

Getting the perspective of Parkinson’s disease patients on their motivations and experiences participating in clinical trials can help increase recruitment and retention of future studies, …

Continue Reading →

Leadless Pacemaker Patients Less Likely to Experience Complications, Major U.S. Study Shows

Research finds use of smaller, self-contained devices reduced complications for up to 18 months compared with conventional designs Pacemakers that don’t use wires to connect …

Continue Reading →

Atlantic Health System enrolling patients in pancreatic cancer clinical trials

All pancreatic cancer studies led by nationally known expert, Dr. Angela Alistar Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. …

Continue Reading →